How Pharma Executives View Future Business Travel
Source: Life Science Leader
By Rob Wright and Dan Schell
In May 2021, Industry Standard Research (ISR) conducted a web-based quantitative survey of 154 pharmaceutical/biotech industry participants. The goals of the study included:
- understanding the barriers to restarting business travel
- assessing comfort level with traveling for business in the wake of the pandemic
- predicting when return to in-person events will occur.
VIEW THE MAGAZINE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up
Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Life Science Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more